| scholarly article | Q13442814 |
| P2093 | author name string | Lisa J Wood | |
| David Crandell | |||
| Charlotte Mao | |||
| Qing Mei Wang | |||
| Nevena Zubcevik | |||
| Eliezer L Bose | |||
| Rose Nadlyne Octavien | |||
| P2860 | cites work | Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease | Q22241146 |
| Lyme disease: a neuropsychiatric illness | Q22241880 | ||
| The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America | Q22242935 | ||
| Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease | Q22250903 | ||
| CGRP and migraine: neurogenic inflammation revisited | Q24595774 | ||
| The pathogenesis of lyme neuroborreliosis: from infection to inflammation | Q24670918 | ||
| Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection | Q27310210 | ||
| Chronic neurologic manifestations of Lyme disease | Q28242348 | ||
| Risk factors for a non-favorable outcome after treated European neuroborreliosis | Q39604197 | ||
| Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS). | Q40012545 | ||
| Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life | Q40086395 | ||
| Lyme disease: an infectious and postinfectious syndrome. | Q40658790 | ||
| Memory impairment and depression in patients with Lyme encephalopathy: Comparison with fibromyalgia and nonpsychotically depressed patients | Q41126325 | ||
| Cerebrovascular Events in Lyme Neuroborreliosis | Q41206622 | ||
| Relations among indexes of memory disturbance and depression in patients with Lyme borreliosis. | Q41675166 | ||
| Dual task cost of walking is related to fall risk in persons with multiple sclerosis | Q44115045 | ||
| Dermatologic manifestations of Lyme disease | Q44634069 | ||
| Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy. | Q46011689 | ||
| Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding. | Q46181782 | ||
| Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques | Q47292608 | ||
| Symptom Clusters and Quality of Life in Subjects With COPD. | Q47318819 | ||
| Pediatric stroke related to Lyme neuroborreliosis: Data from the Swiss NeuroPaediatric Stroke Registry and literature review | Q47363698 | ||
| The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome | Q47557896 | ||
| The Role of Inflammation in the Pain, Fatigue, Sleep Disturbance Symptom Cluster in Advanced Cancer | Q47642060 | ||
| Long-term follow-up of patients with culture-confirmed Lyme disease | Q47721098 | ||
| The pathophysiology of migraine: implications for clinical management | Q47788175 | ||
| Contribution of symptom clusters to multiple sclerosis consequences | Q47813773 | ||
| Evaluation of study patients with Lyme disease, 10-20-year follow-up | Q48707337 | ||
| Sleep Quality in Well-defined Lyme Disease: A Clinical Cohort Study in Maryland | Q49922570 | ||
| Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins | Q28250646 | ||
| Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities | Q28262147 | ||
| Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies | Q28286421 | ||
| Cognitive function in post-treatment Lyme disease: do additional antibiotics help? | Q33966733 | ||
| A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy | Q34007466 | ||
| Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial | Q34208118 | ||
| Tetracycline therapy for chronic Lyme disease | Q34433477 | ||
| Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells | Q34478025 | ||
| Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. | Q34520345 | ||
| Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells | Q34843051 | ||
| Cognitive motor interference for gait and balance in stroke: a systematic review and meta-analysis | Q35538420 | ||
| Inflammation in the pathogenesis of lyme neuroborreliosis | Q35568103 | ||
| Cognitive motor intervention for gait and balance in Parkinson's disease: systematic review and meta-analysis | Q35601056 | ||
| Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library | Q35650795 | ||
| Lyme disease testing by large commercial laboratories in the United States. | Q36283952 | ||
| A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome | Q36328746 | ||
| Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review | Q36409961 | ||
| Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? | Q36542592 | ||
| Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis | Q36943086 | ||
| The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia | Q37042125 | ||
| Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. | Q37308842 | ||
| Possible role of glial cells in the onset and progression of Lyme neuroborreliosis | Q37356125 | ||
| CGRP receptors in the control of pain and inflammation | Q37373944 | ||
| Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice | Q37510608 | ||
| Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster | Q37633785 | ||
| Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials | Q38037980 | ||
| Epidemiology of Lyme disease | Q38496878 | ||
| Critical review of studies trying to evaluate the treatment of chronic Lyme disease | Q38553356 | ||
| Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. | Q38605299 | ||
| Symptom clusters in adults with inflammatory bowel disease. | Q38612265 | ||
| Differences in Symptom Clusters Identified Using Ratings of Symptom Occurrence vs. Severity in Lung Cancer Patients Receiving Chemotherapy | Q38680518 | ||
| Misdiagnosis of early Lyme disease as the summer flu | Q38912023 | ||
| Cancer Symptom Cluster Management. | Q38992942 | ||
| Role of psychiatric comorbidity in chronic Lyme disease. | Q50767518 | ||
| Clinical and neurocognitive features of the post Lyme syndrome. | Q51001977 | ||
| The effect of a cognitive or motor task on gait parameters of diabetic patients, with and without neuropathy. | Q51847673 | ||
| Psychological states and neuropsychological performances in chronic Lyme disease. | Q51979865 | ||
| The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. | Q52022550 | ||
| Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014. | Q55265561 | ||
| Lyme borreliosis | Q56764150 | ||
| The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects | Q57073013 | ||
| Randomized controlled trial of a brief cognitive-behavioral strategies intervention for the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer | Q57160287 | ||
| Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [C]DPA-713 PET | Q60043974 | ||
| Association of small fiber neuropathy and post treatment Lyme disease syndrome | Q64238403 | ||
| Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection | Q67755859 | ||
| CNS manifestations of third stage Lyme disease | Q69046753 | ||
| Sleep quality in Lyme disease | Q71362979 | ||
| Neurologic manifestations in children with Lyme disease | Q71567548 | ||
| A controlled study of cognitive deficits in children with chronic Lyme disease | Q77364122 | ||
| On the radar: Lyme neuroborreliosis, an infectious cause of cerebral vasculitis | Q86689887 | ||
| Correlates of dual task cost of standing balance in individuals with multiple sclerosis | Q88039843 | ||
| Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups | Q88238530 | ||
| Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: The mediating role of subjective stress | Q88669350 | ||
| Cognitive Decline in Post-treatment Lyme Disease Syndrome | Q89263105 | ||
| Cognitive impairments in patients with persistent symptoms attributed to Lyme disease | Q90569630 | ||
| Symptom Clusters in Women With Breast Cancer During the First 18 Months of Adjuvant Therapy | Q90695921 | ||
| Targeting calcitonin gene-related peptide: a new era in migraine therapy | Q91022645 | ||
| The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease | Q92191117 | ||
| Neurocognition in Post-Treatment Lyme Disease and Major Depressive Disorder | Q93002484 | ||
| Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy | Q93009750 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | borreliosis | Q16006998 |
| P304 | page(s) | 464 | |
| P577 | publication date | 2020-08-21 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Symptom Clusters and Functional Impairment in Individuals Treated for Lyme Borreliosis | |
| P478 | volume | 7 |
Search more.